Media Centre
Latest press releases
-
Lynparza approved in Japan for BRCA-mutated metastatic breast cancer
-
Imfinzi approved in Japan for unresectable Stage III non-small cell lung cancer
-
Bydureon receives positive EU CHMP opinion for new BCise device for patients with type-2 diabetes
-
Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer
-
AstraZeneca to share latest data from an industry-leading portfolio that aims to advance clinical understanding of diabetes and CV risk management at ADA 2018
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Karen Birmingham
Director Global Science Media
Rob Skelding
Director Global Media Relations
Matthew Kent
Director Global Media Relations
Gonzalo Viña
Director Global Media Relations
Jacob Lund
Director External Communications, Sweden
Lotta Sjösten
Manager Media Relations, Sweden
US Media Team
